Wechselwirkungen von Minocyclin

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

EMROSI is contraindicated in patients with a history of hypersensitivity to any of the tetracyclines [see Warnings and Precautions (5.1) ]. (Fachinformation zu Minocyclin, Gegenanzeigen)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

EMROSI is contraindicated in patients with a history of hypersensitivity to any of the tetracyclines [see Warnings and Precautions (5.1) ]. (Fachinformation zu Minocyclin, Gegenanzeigen)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

• Concomitant administration of tetracycline reduces atovaquone concentrations; use caution when coadministering. (Fachinformation zu Atovaquon, Arzneimittelwechselwirkungen)

• Tetracycline may reduce atovaquone concentrations; parasitemia should be closely monitored. (Fachinformation zu Atovaquon und Proguanil, Arzneimittelwechselwirkungen)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Calcium bindet diese Arzneistoffe im Darm und kann die aufgenommene Menge stark verringern; die Dosen zeitlich getrennt einnehmen. (NIH Office of Dietary Supplements, Calcium)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Fachinformation zu Calciumacetat, Arzneimittelwechselwirkungen)

Although tetracycline may be concomitantly administered with quinine sulfate, patients should be monitored closely for adverse reactions associated with quinine sulfate. (Fachinformation zu Chinin, Arzneimittelwechselwirkungen)

The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride. (Fachinformation zu Colestipol, Arzneimittelwechselwirkungen)

Drug Interactions Cholestyramine for Oral Suspension USP may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic), or propranolol (basic), as well as tetracycline, penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis. (Fachinformation zu Colestyramin, Arzneimittelwechselwirkungen)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Eisen bindet diese Arzneistoffe im Darm und verringert ihre Aufnahme; die Dosen zeitlich getrennt einnehmen. (NIH Office of Dietary Supplements, Iron)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

…antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides,… (Fachinformation zu Glimepirid, Arzneimittelwechselwirkungen)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Examples of relevant classes of compounds where antacids have been demonstrated to reduce bioavailability include antibiotics (such as quinolones, ampicillin, and tetracyclines), thyroid hormones, ACE inhibitors, statin lipid regulators, and anti-malarials. (Fachinformation zu Lanthancarbonat, Arzneimittelwechselwirkungen)

Caution should be exercised when JUXTAPID is used with other medications known to have potential for hepatotoxicity, such as isotretinoin, amiodarone, acetaminophen (>4 g/day for ≥3 days/week), methotrexate, tetracyclines, and tamoxifen. (Fachinformation zu Lomitapid, Warnhinweise und Vorsichtsmaßnahmen)

Magnesiumhaltige Präparate und Antazida verringern die Aufnahme dieser Arzneistoffe; die Dosen im Abstand von mindestens zwei Stunden einnehmen. (NIH Office of Dietary Supplements, Magnesium)

…antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides,… (Fachinformation zu Pioglitazon und Glimepirid, Arzneimittelwechselwirkungen)

Tetracycline and other drugs that interact with magnesium Simultaneous administration of tetracycline with quinapril hydrochloride reduced the absorption of tetracycline by approximately 28% to 37%, possibly due to the high magnesium content in quinapril tablets. (Fachinformation zu Quinapril, Arzneimittelwechselwirkungen)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Antibiotics Drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as Rocuronium Bromide Injection include certain antibiotics (e.g., aminoglycosides; vancomycin; tetracyclines; bacitracin; polymyxins; colistin; and sodium colistimethate). (Fachinformation zu Rocuronium, Arzneimittelwechselwirkungen)

Drug Interactions Some studies have shown that simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of the following: cimetidine, digoxin, fluoroquinolone antibiotics, ketoconazole, l-thyroxine, phenytoin, quinidine, ranitidine, tetracycline, and theophylline. (Fachinformation zu Sucralfat, Arzneimittelwechselwirkungen)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Zink verringert die Aufnahme von Chinolon- und Tetracyclin-Antibiotika; das Antibiotikum mindestens zwei Stunden vor oder vier bis sechs Stunden nach Zink einnehmen. (NIH Office of Dietary Supplements, Zinc)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

WARNINGS DEMECLOCYCLINE HYDROCHLORIDE, LIKE OTHER TETRACYCLINE-CLASS ANTIBIOTICS, CAN CAUSE FETAL HARM WHEN ADMINISTERED TO A PREGNANT WOMAN. (Fachinformation zu Demeclocyclin, Warnhinweise)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (Fachinformation zu Etynodioldiacetat und Ethinylestradiol, Arzneimittelwechselwirkungen)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Fachinformation zu Minocyclin, Warnhinweise und Vorsichtsmaßnahmen)

The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (Fachinformation zu Vecuronium, Vorsichtsmaßnahmen)

…omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinical use are immunoassays which are specific… (Fachinformation zu Aminophyllin, Arzneimittelwechselwirkungen)

…additional doses of Cisatracurium Besylate Injection, and to determine whether adjustments need to be made to the dose with subsequent administration. † Examples: aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, sodium colistimethate Drug or Drug Class Clinical Implications * Succinylcholine The use of succinylcholine… (Fachinformation zu Cisatracurium, Arzneimittelwechselwirkungen)

…ranitidine famotidine rifabutin felodipine roxithromycin finasteride Sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin * Refer to PRECAUTIONS , Drug Interactions for information regarding table. (Fachinformation zu Theophyllin, Arzneimittelwechselwirkungen)